Treatment of Clostridium difficile infection in pediatric patients

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Expert Review of Gastroenterology & Hepatology

• Publication date

  2015-05-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/17474124.2015.1039988PMID 25912469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.

  2017cited by this paper
• Lack of evidence for an unmet need to treat Clostridium difficile infection in infants aged <2 years: expert recommendations on how to address this issue.

  2015cited by this paper
• Fecal Microbial Transplantation in Early-Onset Colitis: Caution Advised.

  2015cited by this paper
• Clostridium difficile infection.

  2015cited by this paper
• Novel Risk Factors for Recurrent Clostridium difficile Infection in Children

  2015cited by this paper
• Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Pediatric Patients: Encouragement Wrapped in Caution.

  2015cited by this paper
• Fecal microbiota transplantation in the treatment of refractory Clostridium difficile infection in children: an update

  2014cited by this paper
• Clostridium Difficile Colitis: Review of the Therapeutic Approach

  2014cited by this paper
• Dynamics and associations of microbial community types across the human body

  2014cited by this paper
• Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

  2014cited by this paper
• Efficacy of Fecal Microbiota Transplantation in 2 Children With Recurrent Clostridium difficile Infection and Its Impact on Their Growth and Gut Microbiome

  2014cited by this paper
• Fecal Microbiota Transplantation in Children With Recurrent Clostridium difficile Infection

  2014cited by this paper
• Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance

  2014cited by this paper
• Clostridium difficile infection: prevention, treatment, and surgical management.

  2014cited by this paper
• Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study

  2014cited by this paper
• Clostridium difficile Infection Among Children Across Diverse US Geographic Locations

  2014cited by this paper
• Fecal microbiota transplantation: facts and controversies

  2014cited by this paper
• Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism

  2013cited by this paper
• Hyperimmune bovine colostrum for treatment of GI infections

  2013cited by this paper
• Successful use of fidaxomicin in recurrent Clostridium difficile infection in a child.

  2013cited by this paper
• Clostridium difficile infection in children hospitalized due to diarrhea

  2013influential reference
• Clostridium difficile Infection in Infants and Children

  2013cited by this paper
• Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.

  2013cited by this paper
• Clostridium difficile Carriage and Serum Antitoxin Responses in Children with Inflammatory Bowel Disease

  2013cited by this paper
• Probiotics for the Prevention of Clostridium difficle- Associated Diarrhea: A Systematic Review and Meta-analysisi

  2013cited by this paper
• Probiotics for the treatment of Clostridium difficile associated disease.

  2013cited by this paper
• Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection.

  2013cited by this paper
• Clostridium difficile infection in children: a comprehensive review

  2013cited by this paper
• Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in a Child

  2012cited by this paper
• Five Years Experience of Clostridium difficile Infection in Children at a UK Tertiary Hospital: Proposed Criteria for Diagnosis and Management

  2012cited by this paper
• Probiotics for the Prevention of Clostridium difficile–Associated Diarrhea

  2012cited by this paper
• Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota.

  2012cited by this paper
• Evidence of intravenous immunoglobulin as a critical supportive therapy against Clostridium difficile toxin-mediated lethality in mice.

  2011cited by this paper
• Manual of childhood infections.

  2011cited by this paper
• Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the Society for Healthcare Epidemiology of America(SHEA)and the Infectious Diseases Society of America(IDSA)

  2011influential reference
• Probiotics in clostridium difficile Infection.

  2011cited by this paper
• Epidemiology and Risk Factors for Clostridium difficile Infection in Children

  2011cited by this paper
• Probiotics for Prevention and Treatment of Diarrhea

  2011cited by this paper
• Clostridium difficile Carriage in Elderly Subjects and Associated Changes in the Intestinal Microbiota

  2011cited by this paper
• Clostridium difficile infection in hospitalized children in the United States.

  2011cited by this paper
• Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

  2010cited by this paper
• Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases

  2010cited by this paper
• Prevention and medical management of Clostridium difficile infection

  2010cited by this paper
• Fecal Bacteriotherapy for Relapsing Clostridium difficile Infection in a Child: A Proposed Treatment Protocol

  2010cited by this paper
• Treatment with monoclonal antibodies against Clostridium difficile toxins.

  2010cited by this paper
• Management of Clostridium difficile infection: thinking inside and outside the box.

  2010cited by this paper
• Intravenous Immunoglobulin for the Treatment of Clostridium difficile Infection: A Review

  2010cited by this paper
• Prevention of Endemic Healthcare-Associated Clostridium difficile Infection: Reviewing the Evidence

  2010cited by this paper
• Clostridium Difficile Colitis: A Call for Aggressive Management

  2010cited by this paper
• Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection

  2009cited by this paper
• Clostridium difficile-associated disease in children with solid tumors

  2009cited by this paper
• The fascination with probiotics for Clostridium difficile infection: lack of evidence for prophylactic or therapeutic efficacy.

  2009cited by this paper
• European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

  2009cited by this paper
• Epidemiological Features of Clostridium difficile-Associated Disease Among Inpatients at Children's Hospitals in the United States, 2001–2006

  2008influential reference
• Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.

  2008cited by this paper
• Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

  2008cited by this paper
• Response to the article: McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic-associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101:812-22.

  2007cited by this paper
• Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.

  2007cited by this paper
• Alteration of Sulfate and Hydrogen Metabolism in the Human Colon by Changing Intestinal Transit Rate

  2007cited by this paper
• A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

  2007cited by this paper
• Inappropriate use of meta-analysis to estimate efficacy of probiotics.

  2007cited by this paper
• Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease

  2006cited by this paper
• Human Monoclonal Antibodies Directed against Toxins A and B Prevent Clostridium difficile-Induced Mortality in Hamsters

  2006cited by this paper
• Probiotic use in clinical practice: what are the risks?

  2006cited by this paper
• Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

  2005cited by this paper
• A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

  2005cited by this paper
• Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan.

  2005cited by this paper
• Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea.

  2005cited by this paper
• Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

  2004cited by this paper
• Probiotics to enhance anti-infective defences in the gastrointestinal tract.

  2003cited by this paper
• Nondigestible Oligosaccharides Enhance Bacterial Colonization Resistance against Clostridium difficile In Vitro

  2003cited by this paper
• Pseudomembranous and neutropenic enterocolitis in pediatric oncology patients

  2003cited by this paper
• Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.

  2001cited by this paper
• Probiotics: "living drugs".

  2001cited by this paper
• Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil.

  2000cited by this paper
• Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor.

  1992cited by this paper
• Intestinal colonization withClostridium difficile in infants up to 18 months of age

  1989cited by this paper
• Epidemiology of Clostridium difficile colonization in newborns: results using a bacteriophage and bacteriocin typing system.

  1988cited by this paper
• Clostridium difficile and its cytotoxin in infants admitted to hospital with infectious gastroenteritis.

  1984cited by this paper
• Clostridium Difficile in Young Children

  1984cited by this paper
• Epidemiology of Clostridium difficile in infants.

  1982cited by this paper
• CLOSTRIDIUM DIFFICILE TOXIN IN FAECAL SPECIMENS OF HEALTHY CHILDREN AND CHILDREN WITH DIARRHOEA

  1982cited by this paper
• Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study

  1982cited by this paper

• Clostridioides difficile Infections: Prevention and Treatment Strategies.

  2024cites this paper
• Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults

  2022cites this paper
• Clostridium difficile: What is the risk?

  2022cites this paper
• Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study

  2022cites this paper
• The effects of proton pump inhibitors on the microbiome in young children

  2020cites this paper
• Updated Management Guidelines for Clostridioides difficile in Paediatrics

  2020cites this paper
• Diagnostic and Management Strategies for Postoperative Complications in Pediatric Appendicitis

  2019cites this paper
• Clostridium difficile Colitis Prevention and Treatment.

  2019cites this paper
• Immune-Mediated Mechanisms of Action of Probiotics and Synbiotics in Treating Pediatric Intestinal Diseases

  2018cites this paper
• Antibiotic administration and the development of obesity in children.

  2016cites this paper
• [Enteric microbiocenotic modifiers and ways of enhancing their efficacy].

  2015cites this paper